Market Cap

Xenon Pharmaceuticals Inc. Market Capitalization:

$2.73 Billion

USD as of July 1, 2024

business Xenon Pharmaceuticals Inc. Company Profile

Xenon Pharmaceuticals Inc. Main Stock Listing

NASDAQ: XENE

Market Capitalization History of Xenon Pharmaceuticals Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Xenon Pharmaceuticals Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $3.46 B 49.21%
Jan. 1, 2023 $2.32 B 33.81%
Jan. 1, 2022 $1.73 B 88.99%
Jan. 1, 2021 $918.0 M -1.98%
Jan. 1, 2020 $936.6 M 71.43%
Jan. 1, 2019 $546.3 M 166.88%
Jan. 1, 2018 $204.7 M -60.98%
Jan. 1, 2017 $524.6 M 24.05%
Jan. 1, 2016 $422.9 M -62.84%
Jan. 1, 2015 $1.14 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Xenon Pharmaceuticals Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

Xenon Pharmaceuticals Inc. has the following listings and related stock indices.


Stock: NASDAQ: XENE

Stock: FSX: XP0

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.